Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: "On May 14, 2013, a federal agency recommended reducing the threshold for evidence of drunken driving from a blood-alcohol concentration of 0.08 to 0.05. That means having a glass of wine at dinner might make a person drunk, a spokesman for the Tavern League of Wisconsin told the Milwaukee Journal Sentinel the same day. Under a BAC standard of 0.05, a person could get nailed for DUI after one drink? Tavern League’s evidence The statement was made by Scott Stenger, a Madison lobbyist whose clients include the tavern league. He told us he based his claim on news articles about the 0.05 recommendation, including a report from the Journal Sentinel and The Associated Press, and a chart on blood-alcohol concentration from the Texas Alcoholic Beverage Commission. The news covered the recommendation by the National Transportation Safety Board, which investigates transportation accidents and makes recommendations based on its findings. The board said states should cut the current blood-alcohol level for evidence of intoxication as part of a series of ideas aimed at reducing alcohol-related highway deaths. In its report, the Associated Press said 0.05 is ""about one drink for a woman weighing less than 120 pounds,"" and that a drink is defined as 12 ounces of beer, 4 ounces of wine, or 1 ounce of 80-proof alcohol ""in most studies."" Meanwhile, the Texas agency chart that Stenger cited says its BAC data comes from another federal body, the National Highway Traffic Safety Administration, which works to prevent highway crashes. That data says essentially what Stenger and AP did: A 100-pound woman could reach 0.05 after one drink. (Incidentally, both the AP and the chart used by the Texas agency said a 160-pound man could reach 0.05 after consuming two drinks in one hour.) So, there’s evidence that a limited group of drinkers -- women weighing under 120 pounds -- could be legally drunk after one drink, if the standard for drunken driving were reduced to a blood-alcohol level of 0.05. What other evidence is out there? BAC calculators We checked three online calculators that provide blood-alcohol concentration estimates based on various factors, including gender and weight. They generally found a BAC of less than 0.05 for a 100-pound woman consuming one drink. The calculator at the Wisconsin Department of Transportation (which also has a smartphone app), says the BAC would be 0.03. A more detailed calculator from the University of Notre Dame’s Office of Alcohol and Drug Education says the BAC would be 0.04 for a 5-ounce glass of wine, if the wine is red and 12.5 percent alcohol. And the calculator at Central Connecticut State University’s Office of Alcohol and Drug Education says the BAC would be 0.05 after a 5-ounce glass of table wine. So, why do the blood-alcohol concentration figures vary? Well, as we noted, all of the figures are estimates. The Wisconsin DOT also points out that besides gender, weight and the amount of alcohol consumed, other factors are in play. Your BAC will be higher if you drink faster or drink on an empty stomach. Women reach higher BACs faster because they have less water in their bodies and more adipose tissue (fat), which is not easily penetrated by alcohol. Jan Grebel, a chemical test supervisor for the DOT, told us about another factor: If you drink frequently, your liver can break down alcohol more efficiently, but if you don’t, your BAC would be higher after even one drink. Grebel quoted to us from a chart she utilizes when testifying in court in drunken driving cases. She said the chart estimates the BAC at 0.047 -- nearly 0.05 -- for a 100-pound woman after one drink. But Grebel said that would be the maximum BAC in that instance. Most people would not reach 0.05 after one drink, she said. Our rating The Tavern League of Wisconsin said a proposal to make 0.05 the standard for drunken driving would mean that having a glass of wine at dinner could make a person drunk. The statement is accurate, in that it’s possible an individual could reach 0.05 after one drink. But it needs additional information, namely that the situation would apply only in a small number of instances and would depend on other factors, such as drinking on an empty stomach."
[EX A]: A 0.05 standard for drunken driving means having a glass of wine at dinner could make a person drunk.

[EX Q]: "The article doesn't mention costs of angioplasty or costs of medications, which presumably must be taken for the rest of one's life. The article does mention that angioplasty is expensive, but does not provide real numbers or comparisons. The story provides absolute numbers of the primary endpoint over a 4-year period — ""17 percent of those given angioplasty and drugs and nearly 16 percent of those given drugs alone had either died, suffered another heart attack or developed heart failure — results considered to be statistically the same."" The story states that there was a worrisome trend toward more heart attacks in people who received late angioplasty compared to those who received just medications, although the story also tells readers that this could have been a statistical fluke or due to chance. However, other harms of the procedure were not discussed, including risks of the procedure itself, including bleeding, infection, or emotional distress/anxiety. The article also does not discuss risks of the alternative, e.g. medications, which have side effects, costs, or inconvenience. But, the story does discuss the main harm found in the study, e.g. a trend toward increased heart attacks. The research is important because it is a randomized controlled trial and the first such trial to be conducted for the clinical situation of late angioplasty in people with few to no symptoms after their heart attack. The story tells readers that enrollment of patients was delayed because ""doctors were unwilling to risk randomly assigning patients to drug treatment alone,"" indirectly stating that the study was a randomized trial. While an astute reader could probably pick up that this was a randomized trial, this fact could have been clearer. In addition, there is little context around this being the first randomized trial for this clinical situation (as opposed to retrospective observational studies), although the story does tell readers that the results were surprising and that they could change guidelines. The story appropriately describes a heart attack, and more importantly, reinforces that early opening of the artery to restore blood flow to the heart after heart attack is still beneficial and that these results don't apply to that population or indeed the majority of people receiving angioplasties. No obvious disease mongering. The article provides an independent source of information from the chairman of the American Heart Association program committee that reviewed the research. The story also provides information from the director of the National, Heart, Lung, and Blood Institute, but tells readers that this organization largely funded the research, therefore disclosing potential conflicts of interest. The story tells readers that the alternative that was tested in the latest research was medications, including those to lower blood pressure and cholesterol, aspirin, and anti-clotting drugs. The story could have mentioned beta-blockers specifically, since the protective effect of drug treatment may come from this family of drugs, although this is not yet proven. And the story could have been clearer about the course of treatment, e.g. that these medications are generally taken for the rest of one's life. The story tells readers that the usual treatment for people suffering a heart attack is angioplasty, even for a subset of people who weren't treated right away (the study population)/  The article also tells readers that the tendency to perform angioplasty electively (3 to 28 days after the event) was so strong, that recruitment to the study was prolonged in order to find enough patients (and their doctors) willing to participate in the study. It's widely understood that angioplasty and standard drug therapy after heart attack are not new. The article provides independent sources of information not included in the press release."
[EX A]: Study says late angioplasty futile

[EX Q]: The story mentioned that apixabane would cost more than warafarin, and included a quote from a company spokesperson to indicate that the exact price is uncertain as the medication has not yet been approved. The story also presented a reasoned examination of total costs for the use of warafin that accounted not just for per pill costs but also the expenses associated with the routine blood draws to examine warafarin levels. The story provided the absolute decrease in the number of strokes or clots, major bleeding events and hemorrhagic stroke as compared to the people in the study taking warafarin. The story provided good insight about possible problems associated with apixabane in patients with coronary artery disease who were simultaneously taking two blood thinners in addition to apixabane. The story provided a clear explanation about the nature of the patients, the size of the study, and the fact that it was a randomized clinical trial. The story did not engage in overt disease mongering. The story quoted a study researcher, a company spokesperson, and a cardiologist who did not appear to have ties to the study reported on. The story compared the outcome measure of apixabane to warafarin; in addition, it indicated that there is another medication in the same category that has been recently approved by the FDA. The story was clear that apixabane, the medication reported on, was experimental. The story was clear that there is already a similar type of drug that has recently been approved for use by the FDA. While the story referenced a news release, it does not appear to be its sole source of information.
[EX A]:
New Blood Thinner May Outperform Warfarin for Irregular Heartbeat